Behind every abortion debate, there is a human being trying to make the best decision for their life, their health, and their future. And no one should have to make that decision surrounded by lies. Yet today, misinformation and junk science about abortion are more than just noise on social media—they have become powerful tools in legislation, litigation, and even federal regulatory agencies. The latest example involves mifepristone, one of the two medications used in medication abortion. In March, anti-abortion lawmakers in Congress introduced the Clean Water for All Life Act, a bill that used a discredited claim that mifepristone is contaminating drinking water as justification for banning telehealth prescriptions. The bill has not moved, but the idea has not died. Pressure from anti-abortion groups led the Environmental Protection Agency to include mifepristone in a study of potential drinking-water contaminants, and the Food and Drug Administration launched a “safety study” based on a self-published report that has been widely debunked by researchers. This is happening even though the FDA approved mifepristone in 2000 and more than a hundred peer-reviewed studies have consistently shown it to be safe and effective. The gap between what science says and what officials are willing to entertain is not an accident. It reflects a deliberate strategy to create doubt around a medication that has transformed abortion care and expanded access for millions of people, especially after the Supreme Court overturned Roe v. Wade. When junk science enters official proceedings, it gives falsehoods a cloak of legitimacy, making it harder for ordinary people to know what is true. And that confusion feels real, even when the evidence is not.
The false narratives driving these efforts are not new, but they have become more dangerous. The most common claims are that abortion is unsafe, that it damages future fertility, that it causes mental health problems, and that medication abortion is often used to coerce people into ending pregnancies. None of these claims hold up under rigorous scientific review. Anti-abortion advocates rely heavily on studies that fail to meet the basic standards of serious research: they lack transparency, do not make their data available, and cannot be replicated by independent scientists. Anna Bernstein, principal federal policy advisor at the Guttmacher Institute, describes these papers as reaching conclusions that are completely unsupported by their own findings. The calls for restrictions on mifepristone have nothing to do with the outcomes the researchers actually studied, she says, pointing to political motivation rather than scientific method. The harm happens far outside academic debates. Providers see it in their exam rooms every day. Dr. Kassi Avent, a family medicine doctor in New Jersey and fellow with Physicians for Reproductive Health, has provided abortions in multiple states and settings. She says nearly every patient arrives with questions shaped by misinformation. The most common question is “Am I going to be able to have kids in the future?” The fear of losing fertility is so heavy that it can alter how someone feels about their decision in the moment. Instead of receiving clear, compassionate information, they are forced to untangle myths while trying to make one of the most important choices of their lives.
This confusion is not limited to people seeking abortion care. It has seeped into the broader public consciousness. Recent polling from KFF, a health policy research organization, found that awareness of mifepristone has grown significantly since the Dobbs decision, with 60 percent of adults now saying they have heard of the drug. But the same poll found that 41 percent of adults are unsure whether abortion medication is actually safe. Only 22 percent believe it is unsafe—the rest are not sure. That uncertainty is deeply telling. Audrey Kearney, senior survey analyst at KFF, explains that when high-ranking officials question the safety of a medication that has been approved for decades, people naturally begin to wonder why they should trust it. If a drug is being re-reviewed and challenged in court, why would anyone assume it is safe? This is especially true after the COVID-19 pandemic, which left many Americans more skeptical of public health agencies. Kearney notes that people now trust their own doctors more than any institution. A strong relationship with a provider can protect someone from misinformation. But people without that relationship, or people who cannot easily access a doctor, are left in a dangerous state of doubt. They may delay care, avoid telehealth, or travel long distances for procedures they could have accessed easily at home. Misinformation does not just shape opinions—it changes behavior, often in ways that make abortion harder to reach.
Some communities are especially vulnerable to these lies. Lupe M. Rodríguez, executive director of the National Latina Institute for Reproductive Justice, sees a huge amount of targeting aimed at communities already pushed to the margins of the healthcare system. When people do not have regular access to care, they look for information wherever they can find it. For many, that means social media and messaging platforms, which are lifelines for communication. But these same spaces are flooded with misinformation and disinformation that often goes unmoderated and unchecked. Platforms already struggle to fact-check false claims in English, and they are even less equipped—if equipped at all—to handle Spanish-language content. The result is a steady stream of falsehoods that people carry with them into the real world. Rodríguez points to the consequences: rising rates of maternal mortality, shortages of care, dangerous delays, and a compounding fear of immigration enforcement. Misinformation latches onto existing fears and grows stronger in the shadows of that anxiety. Instead of being a source of empowerment, information becomes another barrier. People who need care are forced to navigate not only confusing laws and clinic availability, but also a digital landscape filled with deliberately misleading claims. The people most affected are often those who could least afford the extra burden—those without transportation, without insurance, without a trusted doctor, and without the luxury of sorting through conflicting stories.
The legal system has become another stage for these false narratives. In Louisiana v. FDA, the anti-abortion group Alliance Defending Freedom sued the Food and Drug Administration on behalf of the state and a woman who claimed she had been coerced by her partner into taking abortion medication after receiving it through the mail. The lawsuit sought to reinstate in-person dispensing requirements for mifepristone, arguing that the FDA’s 2023 decision to allow telehealth prescribing was unlawful and dangerous. The plaintiffs cited faulty studies as part of their evidence. On May 1, the Fifth Circuit Court of Appeals granted Louisiana’s request to reinstate in-person dispensing while the appeal was pending, and the order unexpectedly applied nationwide. The next day, defendants in the case, including the manufacturers of mifepristone, filed emergency appeals with the Supreme Court, and telehealth access was preserved for the moment. But the damage had already been done. Vanessa Borjon, director of helpline services at the Chicago Abortion Fund, says confusion was the goal. Every legal whiplash made people question whether medication abortion was safe or effective. People began to wonder if they could schedule an appointment today and still receive their pills by the end of the week. Some, fearing last-minute changes, abandoned telehealth altogether and chose to travel for procedures instead. Everyone deserves the type of care they want, Borjon says, but for many people telehealth works better. It is easier, more private, and more accessible. Making it seem unsafe or unavailable is a way of forcing people into a more difficult path. This is not about protecting health; it is about creating chaos and fear.
Even providers struggle to keep up with the shifting legal landscape. Rulings, appeals, and stays change so quickly that doctors sometimes have to pivot at a moment’s notice. It is even harder for patients. Dr. Bhaskari Burra, an OB-GYN in North Carolina and fellow with Physicians for Reproductive Health, says that any news report about access to a medication disappearing makes people assume it has already disappeared. She sees the message that medication abortion is unsafe as a purposeful and manipulative scare tactic, designed to frighten people out of seeking care. But despite the relentless attacks, advocates are pushing back with accurate information and compassionate support. Kwajelyn Jackson, executive director of the Feminist Center for Reproductive Liberation in Atlanta, points out that social media can also be a place for education and empowerment. With so many voices competing for attention, it can be hard to know which ones to trust. That is why reproductive justice leaders and abortion advocates work hard to make sure accurate stories rise to the top. In states like Florida, where a six-week abortion ban creates immense pressure, people face more anti-abortion presence and more stigma. Dr. Robyn Schickler, chief medical officer at Planned Parenthood of Florida, says patients often arrive scared, bracing for a cold or harsh experience because of all the misinformation they have heard. But after the procedure, many are surprised by how kind everyone was and how smooth the whole process felt. They often say, “Oh, that was it?” The gap between the terrifying stories they expected and the gentler reality they experienced is enormous. The truth, passed from provider to patient and from neighbor to neighbor, is still reaching people. It may be quieter than the noise, but it continues to get through.